CCDRD AG has extensive experience with generic Tiotropium product development compared to the reference product Spiriva®.
- 20 pilot and pivotal trials performed with Tiotropium inhalers in healthy subjects
- systemic safety and pulmonary deposition studies
- highly experienced investigators and study teams in the phase I units available
- standardized training and clinical procedures
- intrasubject and residual variance data available
- information about product aging available